["{\n\"step_by_step_thinking\": \"The relevant documents describe the prevalence of hepatitis C virus (HCV) antibody in patients with hepatocellular carcinoma. None of these studies investigate the expression of c-kit protooncogen in hepatitis B virus-induced chronic hepatitis, cirrhosis and hepatocellular carcinoma. Therefore, there is no data to support or refute a diagnostic role for c-kit protooncogen in these conditions.\",\n\"answer_choice\": \"B\"\n}"]